Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-000107

EVP & Group Pres, Cardiology sold 81,940 shares at $57.50 ($4,711,550)

  • EVP & Group Pres, Cardiology acquired 79,988 shares (option exercise)
  • EVP & Group Pres, Cardiology gave up 10,908 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Fitzgerald Joseph Michael · EVP & Group Pres, Cardiology

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-29 Exercise or conversion : show line 1 in the form +58,189 $16.31 $949,063 256,181 D
2023-12-29 Sale : show line 2 in the form −81,940 $57.50 $4,711,550 174,241 D
2024-01-01 Exercise or conversion : show line 3 in the form +21,799 196,040 D
2024-01-01 Shares withheld for taxes : show line 4 in the form −10,908 $57.81 $630,591 185,132 D
Open-market sales · 81,940 sh · avg $57.50 · $4,711,550

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-12-29 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −58,189 0 D
2024-01-01 Exercise or conversion : show line 6 in the form Performance Share Units −21,799 0 D
Loading xslF345X05/doc4.xml…